John F Steiner
John F Steiner
Bispecific Antibody Ivonescimab Added to Chemotherapy in EGFR-Variant Non-Small Cell Lung Cancer: The HARMONi-A Randomized Clinical Trial [0.03%]
贝伐珠单抗联合化疗治疗表皮生长因子受体变异型非小细胞肺癌：HARMONi-A随机临床试验
HARMONi-A Study Investigators;Wenfeng Fang,Yuanyuan Zhao,Yongzhong Luo et al.
HARMONi-A Study Investigators;Wenfeng Fang et al.
Importance: Patients with epidermal growth factor receptor (EGFR) gene variant nonsquamous non-small cell lung cancer (NSCLC) who have disease progression after prior EGFR tyrosine kinase inhibitor (TKI) therapy have limi...
Review of Type 1 Diabetes [0.03%]
1型糖尿病述评
Gilberto Carlos Garcia Bernal,Andrés Alonso Núñez Soria,David Arturo Bernal González
Gilberto Carlos Garcia Bernal
Riley Jay,Michael Hughes,Kristina M Angelo
Riley Jay
Unpacking the Rise in Early-Onset Cancer: A Healthy Dialogue With Kimmie Ng and Ilana Richman [0.03%]
浅谈早发癌症的诱因——与Kimmie Ng和Ilana Richman展开健康对话
Derek C Angus,Matthew B O&#x;Connor
Derek C Angus
Review of Type 1 Diabetes [0.03%]
1型糖尿病的评估
Sara I Jones,Lillian B Boettcher,Jeffrey A Kuller
Sara I Jones
Review of Type 1 Diabetes [0.03%]
1型糖尿病的評述
Steven R Potter,Alissar El Chediak,Ronald F Parsons
Steven R Potter
Andrew R Olenski,Rachel M Werner
Andrew R Olenski
Joseph G Kohne,Susan R Conway,Steven L Shein
Joseph G Kohne